OptimizeRx's market cap is currently $251.84M. The company's EPS TTM is $0.2; its P/E ratio is -5,196.15; OptimizeRx is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $0.22. See an overview of income statement, balance sheet, and cash flow financials.
